grant

HIV and estrogen effects on hypothalamic regulation of cocaine-related behavior

Organization DREXEL UNIVERSITYLocation PHILADELPHIA, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY202521+ years oldAIDS VirusAccelerationAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAcuteAdultAdult HumanAffectAmenorrheaAquadiolAreaAttenuatedBackBehaviorBehavioralBlood SerumCannulationsCell Communication and SignalingCell SignalingCocaineCoupledCyclicityDREADDsDataDifferences between sexesDiffers between sexesDimenformonDiogynDiogynetsDisinhibitionDopamineDorsumDrug RegulationsDrug usageDrugsERalphaERαESR1ESR1 geneEndocrine Gland SecretionEndocrine systemEndocrine/Metabolic Organ SystemEstraceEstradiolEstradiol Receptor alphaEstradiol Receptor αEstradiol ReceptorsEstradiol-17 betaEstradiol-17betaEstraldineEstrogen Receptor 1Estrogen Receptor alphaEstrogen Receptor αEstrogen ReceptorsEstrogensEstrous CycleEstrusExhibitsFeedsFemaleGeneticGonadal HormonesHIVHIV InfectionsHTLV-III InfectionsHTLV-III-LAV InfectionsHealthHormonalHormonal SystemHormonesHuman Immunodeficiency VirusesHuman T-Lymphotropic Virus Type III InfectionsHydroxytyramineHypothalamic structureHypothalamusImmediate-Early GenesIndividualInfectionIntracellular Communication and SignalingKnowledgeLAV-HTLV-IIILabelLesionLocomotionLymphadenopathy-Associated VirusMedialMediatingMedicationMenopauseMensesMenstrual cycleMenstruationMetabolic/Endocrine Body SystemMiceMice MammalsMicroinjectionsModelingMurineMusNR3A1Nerve CellsNerve UnitNeural CellNeurobiologyNeurocyteNeuronsNucleus AccumbensOvocyclinOvocylinPathway interactionsPeriodicityPersonsPharmaceutical PreparationsPre-Clinical ModelPreclinical ModelsPreoptic AreasProcessProductionProgynonRecoveryRegulationRhythmicityRiskRodentRodentiaRodents MammalsSalineSaline SolutionSerumSex DifferencesSexual differencesSignal TransductionSignal Transduction SystemsSignalingSiteSubstance Use DisorderSystemTestingTestosteroneTherapeutic EstradiolTherapeutic EstrogenTherapeutic HormoneTherapeutic TestosteroneTracerTrans-TestosteroneVentral Tegmental AreaViral DiseasesVirus DiseasesVirus-HIVWomanadulthoodameniaantagonismantagonistattenuateattenuatesbehavior responsebehavioral plasticitybehavioral responsebiological signal transductionco-morbidco-morbiditycocaine behaviorcocaine exposurecocaine motivated behaviorscocaine related behaviorscocaine-associated behaviorscocaine-exposedcomorbiditydesigner receptors exclusively activated by designer drugsdrug usedrug/agentearly onsetendocrine gland/systemestrousexperimentexperimental researchexperimental studyexperimentsexposed to cocaineexposure to cocainefemale infectionshypothalamicinfected femalesinfected womeninfections among womeninfections in femalesinfections in womenmalemenstrual periodmonthly periodmonthly periodsmouse modelmurine modelneurobiologicalneuronalpathwaypreoptic regionreceptor expressionreduced substance usereduction in substance usesex based differencessex-dependent differencessex-related differencessex-specific differencessubstance usesubstance use and disordersubstance use reductionsubstance usingtargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttreatment strategyventral tegmentumviral infectionvirus infectionvirus-induced diseasewomen experiencing infectionswomen infectionswomen with infections
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
HIV infection results in abnormal menstruation and alterations in circulating hormones. HIV infection is also highly

comorbid with drug use. Women who use drugs are at an elevated risk of HIV infection and show accelerated

HIV progression. In rodents, estrous cyclicity and cocaine-related behaviors are both regulated by the medial

preoptic area (mPOA) of the hypothalamus. The mPOA regulates gonadal hormone release which feeds back

onto the mPOA to regulate its activity. The mPOA regulates cocaine-related behaviors through primarily

GABAergic projections to the ventral tegmental area (VTA), which modulates dopamine release in the nucleus

accumbens (NAc). Lesion of the mPOA disrupts estrous cycling and enhances cocaine-induced locomotion.

These mPOA lesion-induced changes are associated with increased cFos expression and dopamine release in

the NAc, together implicating mPOA in both estrous cyclicity and cocaine-related behavior. Our preliminary data

in the EcoHIV mouse model of HIV infection indicate disruptions in estrous cycle following inoculation with

EcoHIV. Further, EcoHIV infection enhanced cocaine-induced locomotor sensitization, a model of cocaine-

related behavioral plasticity, and increased cocaine-induced cFos expression in the NAc. Thus, the mPOA may

represent a common site of dysregulation following EcoHIV infection, leading to alterations in both estrous cycle

and cocaine-related behavior. Consistent with this, we have observed that EcoHIV-infected female mice exhibit

attenuated cFos expression in the mPOA. This R21 proposal will test the overarching hypothesis that EcoHIV

infection dysregulates the mPOA estradiol system, leading to enhanced cocaine-induced locomotor

sensitization. Aim 1 will determine the effects of EcoHIV inoculation and cocaine exposure on estradiol levels

and receptor expression in the mPOA. Aim 2 will determine the effects of EcoHIV inoculation on engagement of

mPOA→VTA and VTA→NAc projections in cocaine-induced locomotor sensitization. Aim 3 will determine the

effect of chemogenetic activation of mPOA→VTA projections on cocaine-induced locomotor sensitization

following EcoHIV infection. It will also determine the effect of an estrogen receptor α antagonist on cocaine-

induced locomotor sensitization following EcoHIV infection. The results of these experiments will identify a

mechanism by which EcoHIV infection alters behavioral response to cocaine and the contribution of the

mPOA→VTA→NAc pathway to cocaine-related behavior following EcoHIV infection. Further, we will gain

significant knowledge of sex differences in the regulation of cocaine-related behavior by the hypothalamus.

Grant Number: 5R21DA060112-02
NIH Institute/Center: NIH

Principal Investigator: JACQUELINE BARKER

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →